Results 1 to 10 of about 52,047 (115)

An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study

open access: yesFrontiers in Pharmacology, 2020
AimPolypharmacy is becoming a global health problem. The aims of this study were to evaluate the temporal trends in the prevalence of polypharmacy in Sweden and to explore polypharmacy disparities by age, gender, education, and immigration status ...
Nai-Qi Zhang   +2 more
exaly   +3 more sources

Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010–2019

open access: yesFrontiers in Pharmacology, 2022
Background: Polypharmacy has become a global health problem and is associated with adverse health outcomes in the elderly. This study evaluated the prevalence of polypharmacy and hyper-polypharmacy in elderly patients in South Korea during 2010–2019 ...
Jungmi Chae   +2 more
exaly   +3 more sources

An overview of prevalence, determinants and health outcomes of polypharmacy

open access: yesTherapeutic Advances in Drug Safety, 2020
A high rate of polypharmacy is, in part, a consequence of the increasing proportion of multimorbidity in the ageing population worldwide. Our understanding of the potential harm of taking multiple medications in an older, multi-morbid population, who are
Mina Khezrian   +2 more
exaly   +2 more sources

Polypharmacy in people with dementia: a nationwide Danish study [PDF]

open access: yesAlzheimer’s Research & Therapy
Background Polypharmacy, particularly central nervous system (CNS)-active polypharmacy, is widespread in individuals with dementia and may accelerate cognitive decline and increase hospitalization and mortality risks. Identifying the extent and trends of
Nelsan Pourhadi   +5 more
doaj   +2 more sources

Multi-Institutional Drug Use Patterns in Hospitalized Older Patients: Retrospective Cross-Sectional Study [PDF]

open access: yesJMIR Medical Informatics
BackgroundA rapidly aging population led to an increase in the number of patients with chronic diseases and polypharmacy. Although investigations on the appropriate number of drugs for older patients have been conducted, there is ...
Chung Chun Lee   +10 more
doaj   +2 more sources

Polypharmacy trajectories among older women with and without dementia: A longitudinal cohort study

open access: yesExploratory Research in Clinical and Social Pharmacy, 2021
Background: Although multiple medications are often utilized to achieve optimal treatment outcomes, polypharmacy (use of five or more medications) among older population is associated with several detrimental effects.
Kailash Thapaliya   +2 more
doaj   +1 more source

Prevalence and factors associated with polypharmacy: a systematic review and Meta-analysis

open access: yesBMC Geriatrics, 2022
Introduction Polypharmacy is commonly associated with adverse health outcomes. There are currently no meta-analyses of the prevalence of polypharmacy or factors associated with polypharmacy.
Mahin Delara   +7 more
doaj   +1 more source

Defining polypharmacy: in search of a more comprehensive determination method applied in a tertiary psychiatric hospital

open access: yesTherapeutic Advances in Psychopharmacology, 2021
Aims: This cross-sectional pharmacoepidemiologic study examined the prevalence of polypharmacy and psychotropic polypharmacy among inpatients in a tertiary psychiatric hospital in Belgium.
Jeroen Govaerts   +8 more
doaj   +1 more source

Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016.

open access: yesPLoS ONE, 2021
Background/objectivesWith an aging population suffering from increased prevalence of chronic conditions in the United States (U.S.), a large portion of these patients are on multiple medications.
Eric H Young   +4 more
doaj   +1 more source

The evolution of polypharmacy: appropriate and problematic polypharmacy, choosing the right strategy and tactics

open access: yesМедицинский совет, 2021
The evolution of polypharmacy, which for many years consisted of quantifying concurrently prescribed drugs, has led to an qualitative description: “appropriate polypharmacy”, which may be beneficial for some patients, and “problematic polypharmacy ...
M. V. Leonova
doaj   +1 more source

Home - About - Disclaimer - Privacy